Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Erratum to: Chordoma: The Quest for Better Treatment Options

Erratum to: Chordoma: The Quest for Better Treatment Options Oncol Ther (2016) 4:53–55 DOI 10.1007/s40487-016-0018-y ERRATUM Erratum to: Chordoma: The Quest for Better Treatment Options Christopher R. Heery To view enhanced content go to www.oncologytherapy-open.com Received: March 24, 2016 / Published online: April 20, 2016 The Author(s) 2016. This article is published with open access at Springerlink.com Erratum to: Oncol Ther EGFR-positive chordoma. Ann Oncol. DOI 10.1007/s40487-016-0016-0 2013;24:1931–6), and the reference for the 9-nitro-camptothecin study should be 43 The author of the above mentioned paper have (Chugh R, Dunn R, Zalupski MM, et al. Phase noticed a mistake in Table 1 following II study of 9-nitro-camptothecin in patients publication and wish to make the following with advanced chordoma or soft tissue sarcoma. correction. J Clin Oncol. 2005;23:3597–604). The reference for the lapatinib study should The corrected Table 1 can be found below. be 36 (Stacchiotti S, Tamborini E, Lo Vullo S, et al. Phase II study on lapatinib in advanced The online version of the original article can be found under doi:10.1007/s40487-016-0016-0. C. R. Heery (&) Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA e-mail: heerycr@mail.nih.gov 54 Oncol Ther (2016) 4:53–55 Table 1 Summary of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Erratum to: Chordoma: The Quest for Better Treatment Options

Oncology and Therapy , Volume 4 (1) – Apr 20, 2016

Loading next page...
 
/lp/springer-journals/erratum-to-chordoma-the-quest-for-better-treatment-options-nAEKDwvTXT
Publisher
Springer Journals
Copyright
Copyright © 2016 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-016-0018-y
Publisher site
See Article on Publisher Site

Abstract

Oncol Ther (2016) 4:53–55 DOI 10.1007/s40487-016-0018-y ERRATUM Erratum to: Chordoma: The Quest for Better Treatment Options Christopher R. Heery To view enhanced content go to www.oncologytherapy-open.com Received: March 24, 2016 / Published online: April 20, 2016 The Author(s) 2016. This article is published with open access at Springerlink.com Erratum to: Oncol Ther EGFR-positive chordoma. Ann Oncol. DOI 10.1007/s40487-016-0016-0 2013;24:1931–6), and the reference for the 9-nitro-camptothecin study should be 43 The author of the above mentioned paper have (Chugh R, Dunn R, Zalupski MM, et al. Phase noticed a mistake in Table 1 following II study of 9-nitro-camptothecin in patients publication and wish to make the following with advanced chordoma or soft tissue sarcoma. correction. J Clin Oncol. 2005;23:3597–604). The reference for the lapatinib study should The corrected Table 1 can be found below. be 36 (Stacchiotti S, Tamborini E, Lo Vullo S, et al. Phase II study on lapatinib in advanced The online version of the original article can be found under doi:10.1007/s40487-016-0016-0. C. R. Heery (&) Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA e-mail: heerycr@mail.nih.gov 54 Oncol Ther (2016) 4:53–55 Table 1 Summary of

Journal

Oncology and TherapySpringer Journals

Published: Apr 20, 2016

There are no references for this article.